Table 1.
Clinicopathologic Factor | Number of Cases | TM4SF1-AS1 | χ2 | P value | |
---|---|---|---|---|---|
High | Low | ||||
Age (years) | 1.149 | 0.2838 | |||
≤65 | 28 | 12 | 16 | ||
>65 | 15 | 9 | 6 | ||
Sex | 0.0244 | 0.8759 | |||
Male | 22 | 11 | 11 | ||
Female | 21 | 10 | 11 | ||
Histology | 3.376 | 0.0661 | |||
Squamous | 11 | 8 | 3 | ||
Adenocarcinoma | 32 | 13 | 19 | ||
Differentiation | 4.044 | 0.0443* | |||
Well | 27 | 10 | 17 | ||
Moderate + poor | 16 | 11 | 5 | ||
Tumor size (cm) | 0.1961 | 0.6578 | |||
≤3 | 24 | 11 | 13 | ||
>3 | 19 | 10 | 9 | ||
Lymphatic node metastasis | 15.24 | <0.0001* | |||
Negative | 27 | 7 | 20 | ||
Positive | 16 | 14 | 2 | ||
TNM stage | 15.26 | 0.0005* | |||
I | 27 | 7 | 20 | ||
II | 7 | 6 | 1 | ||
III | 9 | 8 | 1 |
Notes: *Significant difference (P <0.05). The two-tailed Pearson χ2 test was employed to analyze the correlation of TM4SF1-AS1 expression with clinicopathologic factors.